Chugai Pharmaceutical Co. Ltd. - Other Operating Expenses

Chugai Pharmaceutical Co. Ltd.'s Fiscal Year is From January To December - All Figures are in JPY, Billions.

The item "Other-Operating-Expenses" stands at 95.14 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the highest value at least since 12/31/2011, the period currently displayed.

Chugai Pharmaceutical Co. Ltd.'s second quarter result of 16.01 Billion JPY for the item "Other Operating Expenses" represents a decrease of -23.16 percent compared to it's first quarter result.

Also, Chugai Pharmaceutical Co. Ltd.'s second quarter result of 16.01 Billion JPY for the item "Other Operating Expenses" represents an increase of 500.28 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Chugai Pharmaceutical Co. Ltd.'s second quarter result of 95.14 Billion JPY for the item "Other Operating Expenses" represents an increase of 26.63 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 112.55 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 112.55 Billion Japanese Yens.
The 3 year change is 103.87 Billion Japanese Yens.
The 5 year change is 97.44 Billion Japanese Yens.
The 10 year change is 95.14 Billion Japanese Yens.

The Serie's long term average value is 13.34 Billion Japanese Yens. It's latest available value, on 06/30/2025, is 81.81 Billion Japanese Yens higher, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 06/30/2024, to it's latest available value, on 06/30/2025, is +112.55 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 06/30/2025, to it's latest available value, on 06/30/2025, is 0.0 Billion.